首页> 外文会议>World Congress on COPD >Correction of Immune Disorders in Surgical Patients: Issue of the Day in Modern Surgery
【24h】

Correction of Immune Disorders in Surgical Patients: Issue of the Day in Modern Surgery

机译:手术患者免疫障碍的矫正:现代手术中的缺点

获取原文

摘要

Prevention and treatment of purulent septic complications has been an actual problem in surgery for years. Immune system is the key effector and regulatory part of genetic homogeneity maintenance while immune disorders are considered crucial in pathogenesis of surgical infection. Due to the main pathology, immunodeficiency diagnosed in surgical patients before the operation is aggravated by the operation and many pharmacological drugs that affect the immune status, i.e., phagocytosis, humoral and cellular immunity. Today, clinical immunology is aimed to assess the functional status of immune system as well as to define indications to adequate and specific immunotherapy based on clinical immunological investigations results. Together with routine approaches to treatment of purulent septic complications, i.e., antibacterial and substitute immunotherapy, immunocorrecting therapy provides the correction of secondary immunodeficiency in surgical patients thus being a prospective method to boost immune protection.
机译:预防和治疗脓性化脓性并发症一直是手术中的实际问题多年。免疫系统是遗传均匀性维持的关键效应和调节部分,而免疫障碍被认为是手术感染的发病机制至关重要。由于主要病理学,在手术前诊断出在手术前诊断的免疫缺陷通过影响免疫状态,即吞噬作用,体液和细胞免疫的许多药理药物加剧。如今,临床免疫学旨在评估免疫系统的功能状况,并根据临床免疫研究结果确定适当和特异性免疫疗法的适应症。与常规方法一起治疗脓性化脓性并发症,即抗菌和替代免疫疗法,免疫腐蚀治疗提供了外科患者中的继发免疫缺陷的校正,因此是一种提高免疫保护的前瞻性方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号